CTIC — CTI Biopharma Share News
0.000.00%
HealthcareSpeculativeMid Cap
- $1.20bn
- $1.26bn
- $53.95m
U.S. RESEARCH ROUNDUP-Albemarle, Ellington Financial, Savara
U.S. RESEARCH ROUNDUP-CTI Biopharma, Park National, Playags
U.S. STOCKS ON THE MOVE-First Citizens BancShares, Sarepta, Celsius Holdings
U.S. STOCKS ON THE MOVE-Taboola, US banks, Copper miners
U.S. STOCKS ON THE MOVE-SmileDirectClub, Syneos Health, Upstart
Swedish drugmaker finds alluring poison pill
SOBI plummets on offer to buy CTI BioPharma
CTI BioPharma surges on $1.7 bln buyout offer
European shares fall on jitters ahead of U.S. CPI data (updated)
SOBI plummets after it offers to buy CTI BioPharma
European shares edge higher as US CPI data looms, Credit Agricole gains
Sweden's SOBI makes $1.7 bln offer to buy CTI BioPharma (updated)
Sweden's SOBI makes $1.7 bln offer to buy CTI BioPharma
CTI Biopharma Corp expected to post a loss of 12 cents a share - Earnings Preview
Brief: CTI Biopharma To Report First Quarter 2023 Financial Results And Provide Corporate Update
Brief: Stonepine Capital Management Llc Reports 5.3% Passive Stake In Cti Biopharma Corp As Of April 4 - SEC Filing
Brief: Cti Biopharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
U.S. RESEARCH ROUNDUP-Esperion Therapeutics, Office Properties Income Trust, Radius Global Infrastructure
CTI Biopharma Corp reports results for the quarter ended in December - Earnings Summary